These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21584812)

  • 21. Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.
    Sicard H; Al Saati T; Delsol G; Fournié JJ
    Mol Med; 2001 Oct; 7(10):711-22. PubMed ID: 11713370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. V gamma 9V delta 2 T cell response to colon carcinoma cells.
    Corvaisier M; Moreau-Aubry A; Diez E; Bennouna J; Mosnier JF; Scotet E; Bonneville M; Jotereau F
    J Immunol; 2005 Oct; 175(8):5481-8. PubMed ID: 16210656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
    Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E
    Front Immunol; 2021; 12():625165. PubMed ID: 33777007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer.
    Laplagne C; Meddour S; Figarol S; Michelas M; Calvayrac O; Favre G; Laurent C; Fournié JJ; Cabantous S; Poupot M
    Front Immunol; 2020; 11():1396. PubMed ID: 32733462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
    Nedellec S; Sabourin C; Bonneville M; Scotet E
    J Immunol; 2010 Jul; 185(1):55-63. PubMed ID: 20511557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells.
    Li J; Herold MJ; Kimmel B; Müller I; Rincon-Orozco B; Kunzmann V; Herrmann T
    J Immunol; 2009 Jun; 182(12):8118-24. PubMed ID: 19494338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
    Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
    Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.
    de Bruin RC; Stam AG; Vangone A; van Bergen En Henegouwen PM; Verheul HM; Sebestyén Z; Kuball J; Bonvin AM; de Gruijl TD; van der Vliet HJ
    J Immunol; 2017 Jan; 198(1):308-317. PubMed ID: 27895170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
    Devilder MC; Maillet S; Bouyge-Moreau I; Donnadieu E; Bonneville M; Scotet E
    J Immunol; 2006 Feb; 176(3):1386-93. PubMed ID: 16424165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.
    Kong Y; Cao W; Xi X; Ma C; Cui L; He W
    Blood; 2009 Jul; 114(2):310-7. PubMed ID: 19436053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
    Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
    Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
    Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
    J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
    Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B
    PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
    Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
    J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.
    de Weerdt I; Lameris R; Ruben JM; de Boer R; Kloosterman J; King LA; Levin MD; Parren PWHI; de Gruijl TD; Kater AP; van der Vliet HJ
    Clin Cancer Res; 2021 Mar; 27(6):1744-1755. PubMed ID: 33451981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
    Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
    Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
    Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M
    Blood; 2012 Oct; 120(16):3271-9. PubMed ID: 22932792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
    DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
    Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.